CRONOS GROUP INC. Revenue from Contract with Customer, Including Assessed Tax
CRONOS GROUP INC. (CRON) reported Revenue from Contract with Customer, Including Assessed Tax of $70.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-06
- CRONOS GROUP INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $70.60M, a 59.53% increase year-over-year.
- CRONOS GROUP INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $58.97M, a 40.73% increase year-over-year.
- CRONOS GROUP INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $58.38M, a 41.77% increase year-over-year.
- CRONOS GROUP INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $48.83M, a 4.79% increase year-over-year.
- CRONOS GROUP INC. revenue from contract with customer, including assessed tax for fiscal 2025 was $193.36M, a 19.49% increase from fiscal 2024.
- CRONOS GROUP INC. revenue from contract with customer, including assessed tax for fiscal 2024 was $161.82M, a 34.55% increase from fiscal 2023.
- CRONOS GROUP INC. revenue from contract with customer, including assessed tax for fiscal 2023 was $120.27M, a 10.04% increase from fiscal 2022.
- CRONOS GROUP INC. revenue from contract with customer, including assessed tax for fiscal 2022 was $109.30M, a 37.29% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 12 month | Revenue from Contract with Customer, Including Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $70.60M 10-Q · filed 2026-08-06 | $129.56M 10-Q · filed 2026-08-06 | $187.95M derived: sum of 3 quarters · filed 2026-08-06 | $236.78M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $58.97M 10-Q · filed 2026-05-11 | $117.35M derived: sum of 2 quarters · filed 2026-05-11 | $166.18M derived: sum of 3 quarters · filed 2026-05-11 | $210.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $58.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $107.21M derived: sum of 2 quarters · filed 2026-02-26 | $151.47M derived: sum of 3 quarters · filed 2026-08-06 | $193.36M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $48.83M 10-Q · filed 2025-11-06 | $93.08M derived: sum of 2 quarters · filed 2026-08-06 | $134.98M 10-Q · filed 2025-11-06 | $176.16M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $44.25M 10-Q · filed 2026-08-06 | $86.15M 10-Q · filed 2026-08-06 | $127.33M derived: sum of 3 quarters · filed 2026-08-06 | $173.93M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $41.90M 10-Q · filed 2026-05-11 | $83.08M derived: sum of 2 quarters · filed 2026-05-11 | $129.67M derived: sum of 3 quarters · filed 2026-05-11 | $168.35M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $41.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $87.78M derived: sum of 2 quarters · filed 2026-02-26 | $126.45M derived: sum of 3 quarters · filed 2026-02-26 | $161.82M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $46.59M 10-Q · filed 2025-11-06 | $85.27M derived: sum of 2 quarters · filed 2025-11-06 | $120.64M 10-Q · filed 2025-11-06 | $154.65M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $38.68M 10-Q · filed 2025-08-07 | $74.05M 10-Q · filed 2025-08-07 | $108.05M derived: sum of 3 quarters · filed 2026-02-26 | $141.96M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $35.37M 10-Q · filed 2025-05-08 | $69.37M derived: sum of 2 quarters · filed 2026-02-26 | $103.28M derived: sum of 3 quarters · filed 2026-02-26 | $129.08M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $34.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $67.92M derived: sum of 2 quarters · filed 2026-02-26 | $93.72M derived: sum of 3 quarters · filed 2026-02-26 | $120.27M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $33.91M 10-Q · filed 2024-11-12 | $59.71M derived: sum of 2 quarters · filed 2024-11-12 | $86.26M 10-Q · filed 2024-11-12 | $115.32M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $25.80M 10-Q · filed 2024-08-08 | $52.35M 10-Q · filed 2024-08-08 | $81.41M derived: sum of 3 quarters · filed 2025-02-27 | $107.48M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $26.55M 10-Q · filed 2024-05-09 | $27.20M 10-Q · filed 2023-05-09 | $55.61M derived: sum of 2 quarters · filed 2025-02-27 | $81.68M derived: sum of 3 quarters · filed 2025-02-27 | $108.78M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $29.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $55.13M derived: sum of 2 quarters · filed 2025-02-27 | $82.22M derived: sum of 3 quarters · filed 2025-02-27 | $109.30M 10-K · filed 2025-02-27 | $114.46M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $26.07M 10-Q · filed 2023-11-08 | $26.58M 10-Q · filed 2022-11-07 | $53.16M derived: sum of 2 quarters · filed 2023-11-08 | $80.24M 10-Q · filed 2023-11-08 | $84.54M 10-Q · filed 2022-11-07 | $104.09M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $27.09M 10-Q · filed 2023-08-08 | $28.55M 10-Q · filed 2022-08-09 | $54.17M 10-Q · filed 2023-08-08 | $57.96M 10-Q · filed 2022-08-09 | $78.02M derived: sum of 3 quarters · filed 2024-02-29 | $102.61M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $29.41M 10-Q · filed 2023-05-09 | $50.93M derived: sum of 2 quarters · filed 2024-02-29 | $75.52M derived: sum of 3 quarters · filed 2024-02-29 | $94.36M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $21.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $46.11M derived: sum of 2 quarters · filed 2024-02-29 | $64.96M derived: sum of 3 quarters · filed 2024-02-29 | $79.61M 10-K · filed 2024-02-29 | $89.49M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $24.59M 10-Q · filed 2022-11-07 | $43.44M derived: sum of 2 quarters · filed 2022-11-07 | $58.09M 10-Q · filed 2022-11-07 | $78.05M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $18.85M 10-Q · filed 2022-08-09 | $33.50M 10-Q · filed 2022-08-09 | $53.46M derived: sum of 3 quarters · filed 2023-02-28 | $67.08M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $14.65M 10-Q · filed 2022-05-10 | $34.61M derived: sum of 2 quarters · filed 2023-02-28 | $48.23M derived: sum of 3 quarters · filed 2023-02-28 | $59.66M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $19.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $33.58M derived: sum of 2 quarters · filed 2023-02-28 | $45.01M derived: sum of 3 quarters · filed 2023-02-28 | $54.35M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $13.62M 10-Q · filed 2022-02-18 | $25.05M derived: sum of 2 quarters · filed 2022-02-18 | $34.40M 10-Q · filed 2022-02-18 | $42.31M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $11.43M 10-Q/A · filed 2022-02-18 | $20.78M 10-Q/A · filed 2022-02-18 | $28.69M derived: sum of 3 quarters · filed 2022-03-01 | $34.96M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $9.34M 10-Q · filed 2021-05-07 | $17.26M derived: sum of 2 quarters · filed 2022-03-01 | $23.53M derived: sum of 3 quarters · filed 2022-03-01 | $31.59M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $7.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $14.18M derived: sum of 2 quarters · filed 2022-03-01 | $22.25M derived: sum of 3 quarters · filed 2022-03-01 | $25.64M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $6.27M 10-Q · filed 2020-11-05 | $14.33M derived: sum of 2 quarters · filed 2020-11-05 | $17.72M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $8.06M 10-Q · filed 2020-08-06 | $11.46M 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $3.39M 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | $13.23M 10-K · filed 2021-02-26 | |||||||
| 2017-12-31 | $3.15M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |